Oral Appliance Therapy Series

Oral Appliance Therapy Series

Brand: AASM
SKU: OAT-2026
300.00 USD In stock Buy at Merchant

Stay ahead in the evolving field of sleep medicine with this expert-led educational series on oral appliance therapy for obstructive sleep apnea. Explore the latest evidence-based guidance, gain practical insight into clinical applications, and build confidence navigating treatment options beyond PAP therapy—equipping your team to deliver informed, multidisciplinary patient care. Module Topics: Introduction to Oral Appliance Therapy for OSA A Patient's Journey with Oral Appliance Therapy Anatomy/Physiology of Sleep Apnea and How an Oral Appliance Addresses Pathophysiology Clinical Considerations for The Oral Appliance Therapy Patient Clinical Outcomes and Combination Therapy Oral Appliance Therapy for OSA with Comorbidities Learning Objectives: Upon completion of this activity, participants will be able to: Discuss the various types of appliances that are available and to understand which types of appliances are preferred for OAT. Understand the anatomy and physiology of OSA and how OAT addresses the pathophysiology Discuss the clinical considerations and patient characteristics that might qualify the patient as a candidate for OAT Understand the “patient journey” from diagnosis with OSA through to the successful employment of OAT for OSA. Discuss the clinical outcomes of OAT, including the specific ways in which the clinical polysomnographer may be directly involved in the evaluation and application of OAT in the sleep laboratory. Understand the evolving future of OAT in the personalized care of individuals requiring treatment of OSA Estimated time to complete: 6 hours *Please note that all on-demand modules are non-transferable after purchase. Access is limited to the original purchaser and cannot be resold, accessed or transferred to another individual user.

Variants (1)
  • Default Title — 300.00 USD — In stock

AI Readiness

Good foundation, but some important product data is still missing.

81%